Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens et al.|Journal of Clinical Oncology|2024Cited by 25
Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22<sup>+</sup> acute lymphoblastic leukemia: results of the phase IB ITCC-059 trialEdoardo Pennesi, C. Michel Zwaan, Claudia Rössig et al.|Haematologica|2024Cited by 18
Landscape of early clinical trials for childhood and adolescence cancer in SpainFrancisco Bautista, Lucas Moreno, Soledad Gallego et al.|Clinical & Translational Oncology|2015Cited by 7
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059Jen-Hao Wu, Alwin D. R. Huitema, Edoardo Pennesi et al.|Clinical Pharmacokinetics|2024Cited by 6
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in ChildrenUri Ilan, Francisco Bautista, Erica Brivio et al.|Journal of Clinical Medicine|2023Cited by 6